![](/img/cover-not-exists.png)
DOP48 Amiselimod, a selective S1P receptor modulator in Crohn’s disease patients: a proof-of-concept study
D’Haens, G, Danese, S, Davies, M, Watanabe, M, Hibi, TVolume:
13
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.082
Date:
January, 2019
File:
PDF, 429 KB
2019